New Drug's heart risk under microscope in healthy volunteers
NCT ID NCT07513207
First seen Apr 08, 2026
Summary
This study tests whether a single dose of vicadrostat affects the heart's electrical activity in 45 healthy adults aged 18 to 50. Participants receive vicadrostat, placebo, or moxifloxacin in random order, and heart rhythms are monitored for 24 hours. The goal is purely safety-related, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Humanpharmakologisches Zentrum Biberach
RECRUITINGBiberach, 88397, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.